SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane
- Written by PR Newswire
 |
- First Generic of Abraxane in Korea, World 4th Commercial Scale-Up
- Global tech-transfer expected to US, Japan, and Europe
SEONGNAM, South Korea, Jan. 26, 2023 /PRNewswire/ -- SN BioScience (CEO Park Young-hwan) and Boryeong (CEO Jang Doo-hyun) signed a domestic manufacturing technology transfer and co-development contract for the albumin nanoparticle...
